Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of Influenza A/Hong Kong/123/77 (H1N1) <italic>ts</italic>-1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers</title><author><name sortKey="Murphy, Brian R" sort="Murphy, Brian R" uniqKey="Murphy B" first="Brian R." last="Murphy">Brian R. Murphy</name><affiliation><nlm:aff id="af1">Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205</nlm:aff></affiliation></author><author><name sortKey="Rennels, Margret B" sort="Rennels, Margret B" uniqKey="Rennels M" first="Margret B." last="Rennels">Margret B. Rennels</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Douglas, R Gordon" sort="Douglas, R Gordon" uniqKey="Douglas R" first="R. Gordon" last="Douglas">R. Gordon Douglas</name><affiliation><nlm:aff id="af3">University of Rochester School of Medicine, Rochester, New York 14627</nlm:aff></affiliation></author><author><name sortKey="Betts, Robert F" sort="Betts, Robert F" uniqKey="Betts R" first="Robert F." last="Betts">Robert F. Betts</name><affiliation><nlm:aff id="af3">University of Rochester School of Medicine, Rochester, New York 14627</nlm:aff></affiliation></author><author><name sortKey="Couch, Robert B" sort="Couch, Robert B" uniqKey="Couch R" first="Robert B." last="Couch">Robert B. Couch</name><affiliation><nlm:aff id="af4">Baylor College of Medicine, Houston, Texas 77000</nlm:aff></affiliation></author><author><name sortKey="Cate, Thomas R" sort="Cate, Thomas R" uniqKey="Cate T" first="Thomas R." last="Cate">Thomas R. Cate</name><affiliation><nlm:aff id="af4">Baylor College of Medicine, Houston, Texas 77000</nlm:aff></affiliation></author><author><name sortKey="Chanock, Robert M" sort="Chanock, Robert M" uniqKey="Chanock R" first="Robert M." last="Chanock">Robert M. Chanock</name><affiliation><nlm:aff id="af1">Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205</nlm:aff></affiliation></author><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P." last="Kendal">Alan P. Kendal</name><affiliation><nlm:aff id="af5">Center for Disease Control, Atlanta, Georgia 30333</nlm:aff></affiliation></author><author><name sortKey="Maassab, Hunien F" sort="Maassab, Hunien F" uniqKey="Maassab H" first="Hunien F." last="Maassab">Hunien F. Maassab</name><affiliation><nlm:aff id="af6">Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, Michigan 43104</nlm:aff></affiliation></author><author><name sortKey="Suwanagool, Surapol" sort="Suwanagool, Surapol" uniqKey="Suwanagool S" first="Surapol" last="Suwanagool">Surapol Suwanagool</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Sotman, Steven B" sort="Sotman, Steven B" uniqKey="Sotman S" first="Steven B." last="Sotman">Steven B. Sotman</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Cisneros, Luis A" sort="Cisneros, Luis A" uniqKey="Cisneros L" first="Luis A." last="Cisneros">Luis A. Cisneros</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Anthony, William C" sort="Anthony, William C" uniqKey="Anthony W" first="William C." last="Anthony">William C. Anthony</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Nalin, David R" sort="Nalin, David R" uniqKey="Nalin D" first="David R." last="Nalin">David R. Nalin</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Levine, Myron M" sort="Levine, Myron M" uniqKey="Levine M" first="Myron M." last="Levine">Myron M. Levine</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">7216417</idno><idno type="pmc">551124</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC551124</idno><idno type="RBID">PMC:551124</idno><date when="1980">1980</date><idno type="wicri:Area/Pmc/Corpus">000321</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000321</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Evaluation of Influenza A/Hong Kong/123/77 (H1N1) <italic>ts</italic>-1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers</title><author><name sortKey="Murphy, Brian R" sort="Murphy, Brian R" uniqKey="Murphy B" first="Brian R." last="Murphy">Brian R. Murphy</name><affiliation><nlm:aff id="af1">Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205</nlm:aff></affiliation></author><author><name sortKey="Rennels, Margret B" sort="Rennels, Margret B" uniqKey="Rennels M" first="Margret B." last="Rennels">Margret B. Rennels</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Douglas, R Gordon" sort="Douglas, R Gordon" uniqKey="Douglas R" first="R. Gordon" last="Douglas">R. Gordon Douglas</name><affiliation><nlm:aff id="af3">University of Rochester School of Medicine, Rochester, New York 14627</nlm:aff></affiliation></author><author><name sortKey="Betts, Robert F" sort="Betts, Robert F" uniqKey="Betts R" first="Robert F." last="Betts">Robert F. Betts</name><affiliation><nlm:aff id="af3">University of Rochester School of Medicine, Rochester, New York 14627</nlm:aff></affiliation></author><author><name sortKey="Couch, Robert B" sort="Couch, Robert B" uniqKey="Couch R" first="Robert B." last="Couch">Robert B. Couch</name><affiliation><nlm:aff id="af4">Baylor College of Medicine, Houston, Texas 77000</nlm:aff></affiliation></author><author><name sortKey="Cate, Thomas R" sort="Cate, Thomas R" uniqKey="Cate T" first="Thomas R." last="Cate">Thomas R. Cate</name><affiliation><nlm:aff id="af4">Baylor College of Medicine, Houston, Texas 77000</nlm:aff></affiliation></author><author><name sortKey="Chanock, Robert M" sort="Chanock, Robert M" uniqKey="Chanock R" first="Robert M." last="Chanock">Robert M. Chanock</name><affiliation><nlm:aff id="af1">Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205</nlm:aff></affiliation></author><author><name sortKey="Kendal, Alan P" sort="Kendal, Alan P" uniqKey="Kendal A" first="Alan P." last="Kendal">Alan P. Kendal</name><affiliation><nlm:aff id="af5">Center for Disease Control, Atlanta, Georgia 30333</nlm:aff></affiliation></author><author><name sortKey="Maassab, Hunien F" sort="Maassab, Hunien F" uniqKey="Maassab H" first="Hunien F." last="Maassab">Hunien F. Maassab</name><affiliation><nlm:aff id="af6">Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, Michigan 43104</nlm:aff></affiliation></author><author><name sortKey="Suwanagool, Surapol" sort="Suwanagool, Surapol" uniqKey="Suwanagool S" first="Surapol" last="Suwanagool">Surapol Suwanagool</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Sotman, Steven B" sort="Sotman, Steven B" uniqKey="Sotman S" first="Steven B." last="Sotman">Steven B. Sotman</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Cisneros, Luis A" sort="Cisneros, Luis A" uniqKey="Cisneros L" first="Luis A." last="Cisneros">Luis A. Cisneros</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Anthony, William C" sort="Anthony, William C" uniqKey="Anthony W" first="William C." last="Anthony">William C. Anthony</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Nalin, David R" sort="Nalin, David R" uniqKey="Nalin D" first="David R." last="Nalin">David R. Nalin</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author><author><name sortKey="Levine, Myron M" sort="Levine, Myron M" uniqKey="Levine M" first="Myron M." last="Levine">Myron M. Levine</name><affiliation><nlm:aff id="af2">Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</nlm:aff></affiliation></author></analytic><series><title level="j">Infection and Immunity</title><idno type="ISSN">0019-9567</idno><idno type="eISSN">1098-5522</idno><imprint><date when="1980">1980</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Two attenuated influenza A donor viruses, the A/Udorn/72 <italic>ts</italic>-1A2 and the A/Ann Arbor/6/60 cold-adapted (<italic>ca</italic>) viruses, are being evaluated for their ability to reproducibly attenuate each new variant of influenza A virus to a specific and desired level by the transfer of one or more attenuating genes. Each of these donor viruses has been able to attenuate influenza A viruses belonging to the H3N2 subtype by the transfer of one or more attenuating genes. To determine whether these two donor viruses could attenuate a wild-type virus that belonged to a different influenza A subtype, <italic>ts</italic>-1A2 and <italic>ca</italic> recombinants of a wild-type virus representative of the A/USSR/77 (H1N1) Russian influenza strain were prepared and evaluated in adult doubly seronegative volunteers at several doses. The recombinants derived from both donor viruses were attenuated for the doubly seronegative adults. Less than 5% of infected vaccinees developed a febrile or systemic reaction, whereas five of six recipients of wild-type virus developed such a response. The 50% human infectious dose (HID<sub>50</sub>) for each recombinant was approximately 10<sup>5.0</sup> 50% tissue culture infective doses. The virus shed by the <italic>ts</italic>-1A2 and <italic>ca</italic> vaccinees retained the <italic>ts</italic> or <italic>ca</italic> phenotype, or both. This occurred despite replication of the recombinant viruses for up to 9 days. No evidence for transmission of the <italic>ca</italic> or <italic>ts</italic>-1A2 recombinant virus to controls was observed. A serum hemagglutination inhibition response was detected in less than 50% of the infected vaccinees. However, with the more sensitive enzyme-linked immunosorbent assay, a serological response was detected in 100% of the <italic>ca</italic> vaccinees given 300 HID<sub>50</sub> and approximately 70% of <italic>ca</italic> or <italic>ts</italic> vaccinees who received 10 to 32 HID<sub>50</sub> of virus. These results indicate that the recombinants derived from both donor viruses were satisfactorily attenuated and were stable genetically after replication in doubly seronegative adults although they induced a lower serum hemagglutination inhibition response than that found previously for H3N2 <italic>ts</italic> and <italic>ca</italic> recombinants.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Immun</journal-id><journal-title>Infection and Immunity</journal-title><issn pub-type="ppub">0019-9567</issn><issn pub-type="epub">1098-5522</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7216417</article-id><article-id pub-id-type="pmc">551124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Viral Infections</subject></subj-group></article-categories><title-group><article-title>Evaluation of Influenza A/Hong Kong/123/77 (H1N1) <italic>ts</italic>-1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Murphy</surname><given-names>Brian R.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rennels</surname><given-names>Margret B.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Douglas</surname><given-names>R. Gordon</given-names><suffix>Jr.</suffix></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Betts</surname><given-names>Robert F.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Couch</surname><given-names>Robert B.</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Cate</surname><given-names>Thomas R.</given-names><suffix>Jr.</suffix></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Chanock</surname><given-names>Robert M.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kendal</surname><given-names>Alan P.</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib><contrib contrib-type="author"><name><surname>Maassab</surname><given-names>Hunien F.</given-names></name><xref ref-type="aff" rid="af6">6</xref></contrib><contrib contrib-type="author"><name><surname>Suwanagool</surname><given-names>Surapol</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sotman</surname><given-names>Steven B.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cisneros</surname><given-names>Luis A.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Anthony</surname><given-names>William C.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Nalin</surname><given-names>David R.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Levine</surname><given-names>Myron M.</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib></contrib-group><aff id="af1">Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20205</aff><aff id="af2"><label>2</label>Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201</aff><aff id="af3">University of Rochester School of Medicine, Rochester, New York 14627</aff><aff id="af4">Baylor College of Medicine, Houston, Texas 77000</aff><aff id="af5">Center for Disease Control, Atlanta, Georgia 30333</aff><aff id="af6">Department of Epidemiology, University of Michigan, School of Public Health, Ann Arbor, Michigan 43104</aff><pub-date pub-type="ppub"><month>08</month><year>1980</year></pub-date><volume>29</volume><issue>2</issue><fpage>348</fpage><lpage>355</lpage><abstract><p>Two attenuated influenza A donor viruses, the A/Udorn/72 <italic>ts</italic>-1A2 and the A/Ann Arbor/6/60 cold-adapted (<italic>ca</italic>) viruses, are being evaluated for their ability to reproducibly attenuate each new variant of influenza A virus to a specific and desired level by the transfer of one or more attenuating genes. Each of these donor viruses has been able to attenuate influenza A viruses belonging to the H3N2 subtype by the transfer of one or more attenuating genes. To determine whether these two donor viruses could attenuate a wild-type virus that belonged to a different influenza A subtype, <italic>ts</italic>-1A2 and <italic>ca</italic> recombinants of a wild-type virus representative of the A/USSR/77 (H1N1) Russian influenza strain were prepared and evaluated in adult doubly seronegative volunteers at several doses. The recombinants derived from both donor viruses were attenuated for the doubly seronegative adults. Less than 5% of infected vaccinees developed a febrile or systemic reaction, whereas five of six recipients of wild-type virus developed such a response. The 50% human infectious dose (HID<sub>50</sub>) for each recombinant was approximately 10<sup>5.0</sup> 50% tissue culture infective doses. The virus shed by the <italic>ts</italic>-1A2 and <italic>ca</italic> vaccinees retained the <italic>ts</italic> or <italic>ca</italic> phenotype, or both. This occurred despite replication of the recombinant viruses for up to 9 days. No evidence for transmission of the <italic>ca</italic> or <italic>ts</italic>-1A2 recombinant virus to controls was observed. A serum hemagglutination inhibition response was detected in less than 50% of the infected vaccinees. However, with the more sensitive enzyme-linked immunosorbent assay, a serological response was detected in 100% of the <italic>ca</italic> vaccinees given 300 HID<sub>50</sub> and approximately 70% of <italic>ca</italic> or <italic>ts</italic> vaccinees who received 10 to 32 HID<sub>50</sub> of virus. These results indicate that the recombinants derived from both donor viruses were satisfactorily attenuated and were stable genetically after replication in doubly seronegative adults although they induced a lower serum hemagglutination inhibition response than that found previously for H3N2 <italic>ts</italic> and <italic>ca</italic> recombinants.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000321 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000321 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |